Shilpa Medicare Limited

NSE:SHILPAMED.NS

852 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 11,516.0310,501.12411,400.4939,001.598,988.7517,014.7087,493.5657,300.6936,375.7825,838.9315,481.7633,713.2343,181.8192,902.8572,649.121,664.322958.128
Cost of Revenue 7,969.1694,159.2293,840.9832,707.6892,777.3192,565.8473,560.3793,719.5913,680.9833,254.9143,144.9542,148.91,839.781,743.861,483.8321,011.579696.05
Gross Profit 3,546.8616,341.8957,559.516,293.9016,211.4324,448.8613,933.1863,581.1022,694.7992,584.0172,336.8091,564.3341,342.0391,158.9971,165.289652.743262.078
Gross Profit Ratio 0.3080.6040.6630.6990.6910.6340.5250.4910.4230.4430.4260.4210.4220.3990.440.3920.274
Reseach & Development Expenses 309.558491.023550.605338.09368.991209.019272.766230.161245.143158.77295.21845.89922.9460000
General & Administrative Expenses 2,995.938295.291577.404356.886541.8151.884102.42983.09582.55153.13742.8222.79419.89490.30186.08474.50727.419
Selling & Marketing Expenses 28.68126.225180.165119.2364.23946.14526.86722.31839.52233.28147.57223.68715.1296.9666.1364.4662.552
SG&A 2,180.589321.516757.569476.116606.039198.029129.296105.413122.07386.41890.39246.48135.02397.26792.2278.97329.971
Other Expenses 81.705173.997107.684124.71626.0428.56428.27942.67317.9997.61423.64622.50610.90337.99641.786-102.72681.225
Operating Expenses 2,180.5896,274.0696,301.25,100.9884,485.0223,269.4782,783.0422,185.551,415.6641,529.2641,335.5361,025.541840.27586.648531.285426.293111.196
Operating Income 1,366.272-53.9951,204.0881,187.7441,723.1291,127.5441,150.1441,395.5521,279.1351,054.7531,001.273538.793501.769572.349634.004226.45150.882
Operating Income Ratio 0.119-0.0050.1060.1320.1920.1610.1530.1910.2010.1810.1830.1450.1580.1970.2390.1360.157
Total Other Income Expenses Net -775.081-328.8-181.44762.775157.394229.237217.531114.819-58.10823.652-46.75331.16731.61368.9192.933-150.84716.677
Income Before Tax 591.191-382.7951,022.6491,950.5191,880.5231,356.781,367.6751,510.3711,221.0271,078.405954.52569.96533.382641.268636.93775.603167.559
Income Before Tax Ratio 0.051-0.0360.090.2170.2090.1930.1830.2070.1920.1850.1740.1530.1680.2210.240.0450.175
Income Tax Expense 223.855-73.636416.827488.483334.918261.763339.057446.725233.879352.158203.02595.307119.034146210.98686.02754.362
Net Income 318.743-324.763606.6231,477.8041,561.5341,122.6171,052.4181,090.5131,037.834736.912756.693473.421415.594492.488425.951-10.423113.197
Net Income Ratio 0.028-0.0310.0530.1640.1740.160.140.1490.1630.1260.1380.1270.1310.170.161-0.0060.118
EPS 3.67-3.746.9918.1319.1513.7713.0713.8113.599.610.686.445.727.166.45-0.161.77
EPS Diluted 3.67-3.746.9918.1319.1513.7713.0713.8113.599.610.196.445.727.086.45-0.161.77
EBITDA 2,444.9711,158.7162,212.891,972.2612,254.4351,620.361,637.8521,817.2881,578.5821,334.0691,223.25742.784689.967702.127763.534321.369185.991
EBITDA Ratio 0.2120.110.1940.2190.2510.2310.2190.2490.2480.2280.2230.20.2170.2420.2880.1930.194